Report: FDA to approve Pfizer vaccines for adolescents

The US Food and Drug Administration (FDA) is preparing to authorize use of the Pfizer-BioNTech COVID-19 vaccine in adolescents 12 to 15 years old by early next week, federal officials familiar with the agency’s plans told The New York Times on Monday.

The authorization could come as early as late this week, according to the federal officials, who did not give their names because they weren’t authorized to speak publicly.